Point72 Asset Management, L.P. 13D and 13G filings for AnaptysBio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 10:01 am Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655 (-62.88%) | Filing |
2023-02-14 4:21 pm Sale | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,124,200 7.500% | -157,000 (-6.88%) | Filing |
2022-09-09 4:54 pm Purchase | 2022-08-30 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,281,200 8.100% | 2,009,971 (+741.06%) | Filing |
2022-02-14 4:38 pm Sale | 2021-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 271,229 1.000% | -1,106,713 (-80.32%) | Filing |
2021-01-13 5:06 pm Purchase | 2021-01-04 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 1,377,942 5.000% | 1,377,942 (New Position) | Filing |